4.3 Article

Genetic inactivation of Ikaros is a rare event in human T-ALL

Journal

LEUKEMIA RESEARCH
Volume 34, Issue 4, Pages 426-429

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2009.09.012

Keywords

T cell acute lymphoblastic leukemia; Ikaros; Tumor suppressor; Cytoplasmic retention

Funding

  1. Institut National du Cancer
  2. Ligue contre le Cancer
  3. INSERM
  4. CNRS
  5. University of Strasbourg
  6. Association pour la Recherche sur le Cancer (ARC)
  7. Ligue Regionale Contre le Cancer

Ask authors/readers for more resources

The Ikaros (Ikzf1) gene, encoding a transcription regulator, is a major tumor suppressor in B-cell acute lymphoblastic leukemia (B-ALL). In the mouse, however, loss of Ikaros is primarily associated with T-ALL development. Whether Ikaros is also implicated in human T-ALL remains unclear. We studied Ikaros in 25 human T-ALL samples from diverse molecular subtypes at the mRNA, protein, sequence and genomic copy number level. We found that Ikaros was abnormal in only one sample: one allele was lost by genomic deletion, while proteins generated from the remaining allele were delocalized and concentrated at a single cytoplasmic structure. Thus, inactivation of Ikaros by deletion or mutation is rare in human T-ALL. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available